Description

Company: Hilma Biocare
Active Half-life (Days):  2-3 days
Group: Aromatase inhibitor
Subgroup: Oral/tablets
Dosage: 2.5 mg/tab
Application (Men): 0.5 to 1 mg throughout 1 to 3 days
Product pack: 30 tab.
Content (active): Letrozole
Retains water: No
Aromatization: No

Product Description:

Letrozole is a potent antitumor agent that works as a non-steroidal selective inhibitor of the aromatase enzyme. In medical settings, it is often used in combination with post-menopausal therapy in women and as a treatment for breast cancer. In the athletic community, Letrozole has gained popularity due to its strong anti-estrogenic properties, which can enhance muscle definition and reduce estrogen-related side effects.

Benefits:

By using Letrozole, athletes can nearly eliminate estrogen levels in the body, providing a strong shield against elevated estradiol levels. This can help prevent aromatization and promote a more effective training regimen.

Side Effects:

Common side effects associated with Letrozole include:

• Skin rash
• Nausea
• Abdominal pain
• Fatigue
• Dizziness
• Headache
• Elevated low-density cholesterol levels
• Increased liver enzymes

Precautions:

Before using Letrozole, athletes should undergo a preliminary blood test to assess their estradiol levels. The results can be dramatic, with significant reductions in estradiol and increased effectiveness of the training cycle. Letrozole is commonly used as an anti-estrogenic drug during Post-Cycle Therapy (PCT).

Stacking:

While Letrozole is most effective during PCT, it can also be stacked with clomiphene or other steroids as part of a training cycle.